Page results
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
File results
-
FOI/2023/0938 - Trust pain management education provided to staff
-
FOI/2023/0941 - Paediatric audiology services 2023
-
FOI/2023/0943 - Cancellation of planned surgical procedures
-
FOI/2023/0946 - Treatment of rare diseases; Fabry/ Gaucher/ Pompe disease
-
FOI/2023/0948 - Inpatient wards and bed capacity
-
FOI/2023/0954 - Treatment of melanoma/ Renal cell carcinoma/ Oesophageal cancer
-
FOI/2023/0957 - Maternity services intervention statistics; still birth, elective C-section, emergency C-section
-
FOI/2023/0961 - Robotic Process Automation staff details
-
FOI/2024/0001 - Intrathecal therapy services/ spasticity service
-
FOI/2024/0003 - Translation, interpretation and language service costs - 2019/20 to 2022/2023